-
Je něco špatně v tomto záznamu ?
Development of 3D-Printed Chewable Gummy Tablets with Adjustable Ondansetron Content for the Treatment of Pediatric Patients
M. Veselý, D. Záruba, J. Elbl
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
MUNI/A/1157/2022
Masaryk University
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
- Publikační typ
- časopisecké články MeSH
Background/Objectives: Semi-solid extrusion (SSE) 3D printing is an innovative method utilized for preparation of various drug dosage forms, allowing for individualization by means of incorporation of one or multiple drugs in adjustable doses. SSE provides repeatable results and can be conveniently utilized in small batch production. This study aimed to develop a chewable formulation for pediatric patients which could be easily printed using SSE. Methods: Pectin and gelatin were utilized as gel-forming agents, polyvinylpyrrolidone as a thickener, glycerol as a plasticizer, citric acid as a pH modifier, and potassium sorbate as a conserving agent. Obtained tablets were evaluated for mass and content homogeneity and their mechanical properties compared to the long-time market standard for gummies. Results: Gummy formulation with texture properties comparable to the selected standard and mass homogeneity were prepared. The linear correlation between the model size and ondansetron content was proven. Conclusions: SSE 3D printing thus presents a suitable method of gummy formulation production with possible adjustment of dose by defining the object size.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25014605
- 003
- CZ-PrNML
- 005
- 20250905141343.0
- 007
- ta
- 008
- 250701s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/pharmaceutics17040458 $2 doi
- 035 __
- $a (PubMed)40284453
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Veselý, Martin $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého Tř. 1946/1, 612 42 Brno, Czech Republic $1 https://orcid.org/0000000203528084
- 245 10
- $a Development of 3D-Printed Chewable Gummy Tablets with Adjustable Ondansetron Content for the Treatment of Pediatric Patients / $c M. Veselý, D. Záruba, J. Elbl
- 520 9_
- $a Background/Objectives: Semi-solid extrusion (SSE) 3D printing is an innovative method utilized for preparation of various drug dosage forms, allowing for individualization by means of incorporation of one or multiple drugs in adjustable doses. SSE provides repeatable results and can be conveniently utilized in small batch production. This study aimed to develop a chewable formulation for pediatric patients which could be easily printed using SSE. Methods: Pectin and gelatin were utilized as gel-forming agents, polyvinylpyrrolidone as a thickener, glycerol as a plasticizer, citric acid as a pH modifier, and potassium sorbate as a conserving agent. Obtained tablets were evaluated for mass and content homogeneity and their mechanical properties compared to the long-time market standard for gummies. Results: Gummy formulation with texture properties comparable to the selected standard and mass homogeneity were prepared. The linear correlation between the model size and ondansetron content was proven. Conclusions: SSE 3D printing thus presents a suitable method of gummy formulation production with possible adjustment of dose by defining the object size.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Záruba, David $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého Tř. 1946/1, 612 42 Brno, Czech Republic
- 700 1_
- $a Elbl, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého Tř. 1946/1, 612 42 Brno, Czech Republic $1 https://orcid.org/0000000150535669
- 773 0_
- $w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 17, č. 4 (2025)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40284453 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250701 $b ABA008
- 991 __
- $a 20250905141331 $b ABA008
- 999 __
- $a ok $b bmc $g 2388138 $s 1251725
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 17 $c 4 $e 20250402 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
- GRA __
- $a MUNI/A/1157/2022 $p Masaryk University
- LZP __
- $a Pubmed-20250701